Evidence map›Paper›PMID 38738561›Full record

ArticleEmerging microbes & infections2024

Emergence of multidrug-resistant

Chloé Magnan, Madjid Morsli, Florian Salipante, Blandine Thiry, Julie El Attar, Massimo Di Maio, Maryam Safaria, Tu-Anh Tran, Catherine Dunyach-Remy, Jérôme Ory and 4 more

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Emerging microbes & infections · 2026
    Article
  2. Article
  3. Genetic engineering ofMicrobial genomics · 2026
    Article
  4. Article
  5. Gut microbes · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chloé MagnanVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Madjid MorsliVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Florian SalipanteDepartment of Biostatistics, Epidemiology, Public Health and Innovation in Methodology, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Blandine ThiryVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Julie El AttarVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Massimo Di MaioNeonatal Pediatrics Department, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Maryam SafariaNeonatal Pediatrics Department, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Tu-Anh TranDepartment of Paediatrics, CHU Nîmes, Nîmes, France.
Catherine Dunyach-RemyVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Jérôme OryVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Brigitte Richaud-MorelVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Albert SottoVBIC, Univ Montpellier, INSERM U1047, Department of Infectious Diseases, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Alix PantelVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.
Jean-Philippe LavigneVBIC, Univ Montpellier, INSERM U1047, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Univ. Montpellier, Nîmes, France.ORCID 0000-0002-9484-0304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An emergence of multidrug-resistant (MDR)

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialIntensive Care Units, NeonatalStaphylococcal InfectionsStaphylococcus haemolyticusWhole Genome SequencingCase-Control StudiesCross InfectionFemaleFranceGenome, BacterialGenotypeHumansInfant, NewbornMaleMicrobial Sensitivity TestsAnti-Bacterial Agentsantiseptic resistanceemergencehealthcare associated infectionsmultidrug resistanceneonatal intensive care unitST29Staphylococcus haemolyticuswhole-genome sequencing

Identifiers

PMID38738561
PMCPMC11132433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.